| 01-13-2025 | Microinvasive Glaucoma Surgery (MIGS): HydrusMC Microstent for the Treatment of Mild to Moderate Glaucoma |
| 12-21-2023 | Assessment of InterceptTM and MirasolTM Pathogen Reduction Technologies for the Treatment of Labile Blood Products in Quebec |
| 05-09-2022 | Relevance of the prerequisite of the use of an immunosuppressant drug for the coverage of biologic agents (gastroenterology and dermatology) |
| 05-06-2022 | Assessment of insulin pump systems for type 1 diabetes patients |
| 03-07-2022 | Biologic dose escalation - Gastroenterology, rheumatology and dermatology
|
